Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Get the Prostate.net RSS feed

Category Archives: Treatment

  • Related Categories
    • No categories

Prostate Cancer Drug Galeterone Finishes Phase I Study

by Editor on April 1 Leave the first comment

Another new drug is in the pipeline for treatment of men who have prostate cancer resistant to hormone therapy (castration-resistant prostate cancer). Galeterone, a product of Tokai Pharmaceuticals, was well tolerated, showed efficacy, and had minimal side effects in a Phase 1 study. Galeterone is one of the latest future prostate cancer treatments on the horizon…. Continue Reading »


More about:

Is Proton Therapy for Prostate Cancer Safe?

by James Craig on January 7 Leave the first comment

Researchers at the University of Florida in Jacksonville, Fla. studied 211 men with low, intermediate, and high-risk prostate cancer who were treated with proton therapy, a type of external beam radiation therapy (EBRT) that delivers high doses of protons to a targeted area, which radiation oncologists can achieve using advanced imaging techniques that allow them… Continue Reading »


More about:

Hormone Therapy and Blood Clot Risk for Prostate Cancer Patients

by Deborah Mitchell on December 2 Leave the first comment

For men with prostate cancer who are being treated with hormone therapy, news of a potentially dangerous side effect of hormone therapy associated with their prostate cancer treatment suggests it’s time to talk to their doctor. A large study conducted by researchers at Memorial-Sloan Kettering Cancer Center found that older men with prostate cancer who… Continue Reading »


More about:

Are Older Men Undertreated for Prostate Cancer?

by Deborah Mitchell on September 27 Leave the first comment

To treat or not to treat prostate cancer? That is frequently the question when it comes to older men and treatment for prostate cancer. Is it feasible to subject men who are, say, 75 years and older to prostate cancer treatments that may cause them significant side effects given they may not live much longer?… Continue Reading »


More about: ,

New Prostate Cancer Drug Alpharadin Improves Survival

by Deborah Mitchell on September 24 Leave the first comment

It’s not often that the monitoring committee during a Phase III trial ends the study early because the drug has performed so well, but that’s what happened with the new prostate cancer drug, Alpharadin. The investigators report that men with metastatic, hormone-resistant prostate cancer lived a median of three months longer when taking Alpharadin.


More about: , ,

Botox Approved For Urinary Incontinence

by Editor on August 28 Leave the first comment

The Food and Drug Administration has approved Botox (onabotulinumtoxin A) for treatment of urinary incontinence that is the result of a neurologic condition, such as multiple sclerosis or a spinal cord injury, in adults who have not responded to or who cannot tolerate anticholinergic medications. Currently, the FDA approval does not extend to other causes… Continue Reading »


More about:

Prostate Cancer Drug Alpharadin Gets FDA Support

by Editor on August 24 Leave the first comment

The Food and Drug Administration (FDA) has announced it will fast-track the new prostate cancer drug Alpharadin. Fast-tracking a drug speeds up its approval process by around six months.


More about:

Genetic Markers Linked to Aggressive Prostate Cancer

by James Craig on August 19 Leave the first comment

From a field of 156 candidate genes, scientists have discovered five genetic markers significantly associated with aggressive prostate cancer. This is an important find, not only because it may help clinicians identify which men are at greatest risk of dying of prostate cancer, but also because it could help researchers develop a simple blood test… Continue Reading »


More about:

Sexual Dysfunction in Men with BPH

by Deborah Mitchell on August 15 Leave the first comment

If you are a man who has benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS), chances are you’re also experiencing some sexual dysfunction. Unfortunately, along with the urinary urgency, dribbling, and getting up five times a night to go to the bathroom, sexual dysfunction is also associated with BPH/LUTS. But are you… Continue Reading »


More about:

Treatment for Prostate Cancer Attacks Stem Cells

by James Craig on August 15 Leave the first comment

A possible new treatment for advanced prostate cancer may come in the form of an approach that attacks stem cell-like cells. The new therapy is under investigation by researchers at Lund University and Skane University Hospital in Malmo, Sweden. Even though prostate tumors are believed to contain only about 0.1 percent cancer stem cells, Anders… Continue Reading »


More about:

  • ADVERTISEMENT



  • ADVERTISEMENT